Canandaigua National Trust of Florida’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
11,567
-4,646
-29% -$536K 1.12% 18
2025
Q4
$1.71M Buy
16,213
+3,396
+26% +$319K 1.07% 18
2025
Q3
$1.08M Sell
12,817
-4,511
-26% -$372K 0.85% 22
2025
Q2
$1.37M Buy
17,328
+7,001
+68% +$556K 0.98% 21
2025
Q1
$927K Buy
10,327
+2,939
+40% +$274K 0.82% 26
2024
Q4
$735K Buy
7,388
+3,809
+106% +$393K 0.57% 44
2024
Q3
$406K Buy
+3,579
New +$425K 0.35% 70

Other funds holding MRK

Canandaigua National Trust of Florida's MRK Position: Q1 2026 in Review

Canandaigua National Trust of Florida reduced its Merck (MRK) stake by 29% in Q1 2026, selling an estimated $536K and leaving 11,567 shares worth $1.39M. The position accounts for 1.12% of the portfolio, ranked #18.

Canandaigua National Trust of Florida first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.71M in Q4 2025. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Canandaigua National Trust of Florida held 11,567 shares of Merck worth $1.39M as of Q1 2026.
  • Canandaigua National Trust of Florida sold 4,646 Merck shares in Q1 2026, an estimated $536K.
  • Merck made up 1.12% of Canandaigua National Trust of Florida's portfolio in Q1 2026, its #18 holding.
  • Canandaigua National Trust of Florida first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • Canandaigua National Trust of Florida's Merck position peaked at $1.71M in Q4 2025.
  • 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.